Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature...

Study reveals key insights for preventing cytomegalovirus spread to fetuses

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the...

Perceived stress linked to worsened symptoms in COPD patients

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive...

Genomic sequencing-based detection system cuts infections and saves lives

An infectious diseases detection platform developed by University of Pittsburgh scientists working with UPMC infection preventionists proved over...

HHS and NIH announce the development of next-generation, universal vaccine platform

Colorized transmission electron micrograph of influenza A/H1N1 virus particles. The U.S. Department of Health and Human Services (HHS)...

Increased allergy symptoms tied to changing climate patterns

A review published in The Laryngoscope indicates that climate change's effects on pollen seasons and concentrations are contributing...

Stress and obesity found to fuel early pancreatic cancer growth

Findings A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work...

Clinical trial of vaccine candidate to prevent Lassa fever begins enrollment

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun...

Bach2 protein identified as key regulator in atopic dermatitis

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social...

New human antibody shows promise for Ebola virus treatment

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human...

Asthma and allergy rates higher among First Nations people in Australia

Researchers at The University of Queensland have found First Nations people are twice as likely to present at...

New antibiotic offers hope for more effective Lyme disease treatment

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then...

Omalizumab outperforms oral immunotherapy in treating multi-food allergy

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than...

Probiotics improve emotional state in healthy adults, study finds

Daily mood reports reveal what traditional questionnaires miss — probiotics may lift negative emotions in healthy people, opening...

Scientists uncover why Lyme disease symptoms may linger after treatment

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14%...

How to manage allergies in children

When a child's sniffles and sneezing won't go away for weeks, the cause might be allergies. Long-lasting sneezing,...

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is...

Granzyme K identified as key trigger of complement system in autoimmune diseases

Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One...

New study reveals hidden spread of C. diff in intensive care units

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times...

Social media and peer pressure fueling dangerous drug misuse

Social media trends and peer pressure can be a dangerous combination to your children and their friends, especially...

Study explores how nanoplastics could affect child’s immune system during pregnancy

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb. A team led by Empa researcher Tina Bürki is investigating the possible causes of this. The focus is on nanoplastic particles, which could lead to the development of a hypersensitive immune system in the child. The project is supported by the Eduard Aeberhardt Foundation and another foundation.

Asthma, hay fever or chronic skin conditions: The occurrence of allergic reactions is diverse and on the rise. Among other things, environmental factors during the child's early development in the womb are suspected, which lay the foundation for later illnesses. A team of researchers from Empa, ETH Zurich, EPFL, the University of Zurich and the Cantonal Hospital of St. Gallen is now focusing on micro- and nanoplastics. It is already known that the tiny plastic particles enter the body of pregnant women via drinking water, food and air and find their way to the unborn child. Here they could affect the fragile immune system of mother and child. Moreover, they are able to transport other pollutants, allergens and pathogens.

The new research project now aims to provide a holistic view of the significance of plastic particles during pregnancy. To achieve this, experts from the fields of materials science, cell biology and allergy research are working together with clinical experts. The project is funded by the Eduard Aeberhardt Foundation and another foundation.

Correctly assessing risk

The team led by project manager Tina Bürki and Sina Ruhstaller from Empa's Particles-Biology Interactions laboratory in St. Gallen are particularly interested in the placenta, the central inter-face between mother and child. The organ forms exclusively during pregnancy and supplies the child with nutrients and messenger substances for a healthy development. The placenta could therefore play a decisive role when it comes to the immune response of mother and child to foreign substances.

It is already clear that nanoparticles can disrupt the communication between the placenta and the unborn child. However, the effect of micro- and nanoplastics on the immunological func-tion of the placenta and the effects on the fetal immune system have not yet been elucidated. "There is thus an urgent need for a correct risk assessments of environmental pollutants for pregnant women," says Bürki.

In order to analyze the entire process of nanoparticle exposure, the researchers will examine the micro- and nano-abrasion of everyday plastic products and evaluate the interactions with typi-cal allergy-causing substances and pollutants. Finally, using cell cultures of the human placenta and fetal blood cells, the transport in the body and the reaction to the various particles and pollutant-particle combinations can be mapped as realistically as possible.

By releasing hor-mones and other mediators, the contaminated placenta could contribute to abnormal devel-opments in the child's immune system."

Tina Bürki, Empa researcher

For the sustainable use of safe plastic products, it is therefore essential to know whether and which polymers have an increased po-tential to trigger allergies, says the Empa researcher.

Source:

Empa


Source: http://www.news-medical.net/news/20250206/Study-explores-how-nanoplastics-could-affect-childs-immune-system-during-pregnancy.aspx

Inline Feedbacks
View all comments
guest